Underprescription of beneficial medicines in older people: Causes, consequences and prevention

被引：85

作者：

Cherubini A. ^{[1
,2
]}

Corsonello A. ^{[3
]}

Lattanzio F. ^{[4
]}

机构：

[1] Geriatric Hospital, Italian National Research Centres on Aging (INRCA), 60100, Ancona, via della Montagnola

[2] Institute of Gerontology and Geriatrics, University of Perugia, Medical School, Perugia

[3] Unit of Geriatric Pharmacoepidemiology, Italian National Research Centre on Aging (INRCA), Cosenza

[4] Scientific Direction, Italian National Research Centres on Aging (INRCA), Ancona

来源：

Drugs & Aging | 2012年 / 29卷 / 6期

关键词：

Drug-utilisation; Elderly; Medication-errors; Prescribing;

D O I：

10.2165/11631750-000000000-00000

中图分类号：

学科分类号：

摘要：

Underprescription of potentially useful drugs is widespread among older people and may herald several adverse outcomes. We aimed to review the evidence pertaining to the epidemiology, causes and consequences of underprescribing, as well as recent advances in the development of interventions able to reduce underprescribing and improve outcomes in older people.Underprescribing is highly prevalent across different settings, including in the community, hospitals and nursing homes. Multimorbidity, polypharmacy, ageism, lack of scientific evidence, fear of adverse events and economic problems may contribute to the underprescription of indicated drugs, although in some patients, a limited life expectancy, the lack of a favourable risk-to-benefit ratio or a patients refusal might represent appropriate reasons not to prescribe a drug.Selected interventions may help to improve the quality of prescriptions and reduce the burden of underprescribing. Among these, comprehensive geriatric assessment (CGA) has been demonstrated to effectively improve prescribing practice. Interventions based on service delivery changes, such as those that include a clinical pharmacist or a case manager in the process of care, were also found to improve the quality of pharmacological prescriptions. Educational interventions may also be effective in reducing underprescribing.More recently, the clinical application of the Screening Tool to Alert Doctors to Right Treatment (START) criteria has been able to significantly reduce underprescribing. Since START criteria are easier to apply in clinical practice than other instruments, it is conceivable that their systematic use may contribute to reducing underprescribing and to improving health outcomes in older patients. © 2012 Springer International Publishing AG. All rights reserved.

引用

页码：463 / 475

页数：12

共 110 条

[1]

Christensen K., Doblhammer G., Rau R., Et al., Ageing populations: The challenges ahead, Lancet, 374, 9696, pp. 1196-1208, (2009)

[2]

Shi S., Morike K., Klotz U., The clinical implications of ageing for rational drug therapy, Eur. J. Clin. Pharmacol., 64, 2, pp. 183-199, (2008)

[3]

Laroche M.L., Charmes J.P., Bouthier F., Et al., Inappropriate medications in the elderly, Clin. Pharmacol. Ther., 85, 1, pp. 94-97, (2009)

[4]

Boyd C.M., Darer J., Boult C., Et al., Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: Implications for pay for performance, JAMA, 294, 6, pp. 716-724, (2005)

[5]

Tinetti M.E., Bogardus Jr. S.T., Agostini J.V., Potential pitfalls of disease-specific guidelines for patients with multiple conditions, N. Engl. J. Med., 351, 27, pp. 2870-2874, (2004)

[6]

Cherubini A., Del Signore S., Ouslander J., Et al., Fighting against age discrimination in clinical trials, J. Am. Geriatr. Soc., 58, 9, pp. 1791-1796, (2010)

[7]

Cherubini A., Oristrell J., Pla X., Et al., The persistent exclusion of older patients from ongoing clinical trials regarding heart failure, Arch. Intern. Med., 171, 6, pp. 550-556, (2011)

[8]

Johnson J.A., Bootman J.L., Drug-related morbidity and mortality: A cost-of-illness model, Arch. Intern. Med., 155, 18, pp. 1949-1956, (1995)

[9]

Hanlon J.T., Schmader K.E., Koronkowski M.J., Et al., Adverse drug events in high risk older outpatients, J. Am. Geriatr. Soc., 45, 8, pp. 945-948, (1997)

[10]

Bootman J.L., Harrison D.L., Cox E., The health care cost of drug-related morbidity and mortality in nursing facilities, Arch. Intern. Med., 157, 18, pp. 2089-2096, (1997)

← 1 2 3 4 5 6 7 8 9 10 →